| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1636982A Synthesis of intermediates useful in preparing tricyclic compounds |
| 07/13/2005 | CN1636981A Uracil compounds and their use |
| 07/13/2005 | CN1636976A Mutilin derivatives and their use as antibacterials |
| 07/13/2005 | CN1636967A Noval compounds, their use and preparation |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210256C Diacylhydrazine derivs |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916956 Calcium receptor antagonist |
| 07/12/2005 | US6916934 Such as 1-(pyridinyl)-1,1-dialkoxy-2-aminoethane derivatives; for pollution control; continuous/batch processing |
| 07/12/2005 | US6916933 4-pyridinyl-n-acyl-l-phenylalanines |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916848 Compounds for the treatment of metabolic disorders |
| 07/12/2005 | US6916812 Dietetic agents |
| 07/12/2005 | US6916797 α-arylethylpiperazine derivatives as neurokinin antagonists |
| 07/12/2005 | US6916347 Making 2-amino-5-substituted-amino-phenol derivatives by reduction, hydrogenation, amination, hydroxylation; oxidation color dyes, hair dye mixture including coupler and developer oxidizers, yellow color shades, colorfastness |
| 07/12/2005 | US6916345 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres |
| 07/07/2005 | WO2005061476A2 Aroylfuranes and aroylthiophenes |
| 07/07/2005 | WO2005061465A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors |
| 07/07/2005 | WO2005061464A1 Herbicidal heteroaroyl-substituted phenylalanine amides |
| 07/07/2005 | WO2005061459A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | WO2005061458A2 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 07/07/2005 | WO2005061450A2 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | WO2005061443A2 Benzoyl-substituted phenylalanine amides |
| 07/07/2005 | WO2005061442A1 Opioid receptor antagonists |
| 07/07/2005 | WO2005061439A1 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists |
| 07/07/2005 | WO2005061433A2 Aminoalcohol derivatives |
| 07/07/2005 | WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | WO2005060456A2 Method for treating adamts-5-associate disease |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2005042498A3 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 07/07/2005 | WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/07/2005 | WO2005032471A3 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/07/2005 | US20050148772 Methods and compositions for detecting polynucleotide duplex damage and errors |
| 07/07/2005 | US20050148662 compounds possess the ability to recognize and promote oxidation and allow for scission of a nucleic acid at specific positions and splitting (if exposed to piperidine) |
| 07/07/2005 | US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 07/07/2005 | US20050148638 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 07/07/2005 | US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals |
| 07/07/2005 | US20050148623 HIV protease inhibiting compounds |
| 07/07/2005 | US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/07/2005 | US20050148611 Compounds capable of activating cholinergic receptors |
| 07/07/2005 | US20050148599 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 07/07/2005 | US20050148595 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 07/07/2005 | US20050148584 N-(3-(2-(4-morpholino)ethyloxy)phenyl)-N-{(cis3-(benzylamino)cyclohexyl)methyl}-N'-phenylurea; useful for the treatment of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 07/07/2005 | US20050148086 Fluorescent sensor for phosphate ion and phosphorylated peptide |
| 07/07/2005 | DE10358539A1 Carbonsäureamidderivate Carboxamide |
| 07/07/2005 | DE10357570A1 New 7-amino-5-halo-pyrazolo-(1,5-a)-pyrimidine derivatives, useful as microbicides, especially fungicides or bactericides for protecting plants or materials such as wood |
| 07/07/2005 | CA2792483A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | CA2549389A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2549009A1 Opioid receptor antagonists |
| 07/07/2005 | CA2549007A1 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists |
| 07/07/2005 | CA2548824A1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 07/07/2005 | CA2548513A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | CA2548442A1 Benzoyl-substituted phenylalanine amides |
| 07/07/2005 | CA2548354A1 Herbicidal heteroaroyl-substituted phenylalanine amides |
| 07/07/2005 | CA2547617A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 07/07/2005 | CA2547575A1 Method for treating adamts-5-associated disease |
| 07/06/2005 | EP1550461A1 Remedy for chronic disease |
| 07/06/2005 | EP1549642A1 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
| 07/06/2005 | EP1549622A1 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists |
| 07/06/2005 | EP1549613A1 Sulfonamides having antiangiogenic and anticancer activity |
| 07/06/2005 | EP1549607A2 Diastereoselective method of preparing olefins by means of the horner-wadsworth-emmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 07/06/2005 | CN1636154A Di-substituted iminoheterocyclic compounds |
| 07/06/2005 | CN1635979A IL-8 receptor antagonists |
| 07/06/2005 | CN1635911A Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 07/06/2005 | CN1635890A Neuroprotective 2-pyridinamine compositions and related methods |
| 07/06/2005 | CN1635877A Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/06/2005 | CN1634888A Process for preparing acetyl substituted nitrogen containing heterocyclic compound |
| 07/06/2005 | CN1209352C Hydrazine derivatives |
| 07/06/2005 | CN1209336C Process for preparation of 2-halobenzoic acids |
| 07/06/2005 | CN1209016C Fungicides |
| 07/05/2005 | US6914160 Oxytocin inhibitors |
| 07/05/2005 | US6914144 Process for preparing integrin antagonist intermediate |
| 07/05/2005 | US6914079 Antiproliferative agents; anticancer agents |
| 07/05/2005 | US6914062 Pyrazinone derivatives |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 07/05/2005 | CA2160128C Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058877A1 Novel chelating agents and highly luminescent and stable chelates and their use |
| 06/30/2005 | WO2005058868A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | WO2005058841A2 Hiv protease inhibiting compounds |
| 06/30/2005 | WO2005058840A2 Method of coloring with capped diazotized compound and coupling component |
| 06/30/2005 | WO2005058833A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 06/30/2005 | WO2005058832A1 Diacylhydrazine derivatives |
| 06/30/2005 | WO2005058831A1 Novel herbicides |
| 06/30/2005 | WO2005058830A1 Novel herbicides |
| 06/30/2005 | WO2005058829A1 Compounds for treatment of cell proliferative diseases |
| 06/30/2005 | WO2005058828A1 2-pyridinylethylbenzamide derivatives |
| 06/30/2005 | WO2005058827A1 Process for the synthesis of pioglitazone hydrogen chloride |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |